Pathways Controlling the Expression of Surface CD21 (CR2) and CD23 (Fc_εIIR) Proteins in Human Malignant B Cells

References

• Fearon D. T., Carter R. H. The CD19/CR2/TAPA‐1 complex of B lymphocytes: linking natural to acquired immunity. Ann. Rev. Immunol. 1995; 13: 127–149
   PubMed Web of Science ®Google Scholar
• Cooper N. R., Moore M. D., Nemerow G. R. Immunobiology of CR2. the B lymphocyte receptor for Epstein‐Barr virus and C3d complement receptor fragment. Ann. Rev. Immunol. 1988; 6: 85–113
   PubMed Web of Science ®Google Scholar
• Molina H., Brenner C., Jacobi S., Gorka J., Carel J. C., Kinoshita T., Holers V. M. Analysis of Epstein‐Barr virus‐binding sites on complement receptor 2 (CR2/CD21) using human‐mouse chimeras and peptides. At least two distinct sites are necessary for ligand‐receptor interaction. J. Biol. Chem. 1991; 266: 12173–12179
   PubMed Web of Science ®Google Scholar
• Delcayre A. X., Salas F., Mathur S., Kovats K., Lotz M., Lernhardt W. Epstein‐Barr virus/complement C3d receptor is an interferon alpha receptor. EMBO J. 1991; 10: 919–926
   PubMed Web of Science ®Google Scholar
• Luxembourg A. T., Cooper N. R. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. J. Immunol. 1994; 153: 4448–4457
   PubMed Web of Science ®Google Scholar
• Delibrias C. C., Mouhoub A., Fischer E., Kazatchkine M. D. CRI(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus. Eur. J. Immunol. 1994; 24: 2784–2788
   PubMed Web of Science ®Google Scholar
• Carter R. H., Fearon D. T. Polymeric C3dg primes human B lymphocytes for proliferation induced by anti‐lgM. J. Immunol. 1989; 143: 1755–1760
   PubMed Web of Science ®Google Scholar
• Bonnefoy J. Y., Gauchat J. F., Life P., Graber P., Aubry J. P., Lecoanet‐Henchoz S. Regulation of IgE synthesis by CD23/CD21 interaction. Int. Arch. Allergy Immunol. 1995; 107: 40–42
   PubMed Web of Science ®Google Scholar
• Henchoz S., Gauchat J. F., Aubry J. P., Graber P., Pochon S., Bonnefoy J. Y. Stimulation of human IgE production by a subset of anti‐CD21 monoclonal antibodies: requirement of a co‐signal to modulate epsilon transcripts. Immunology 1994; 81: 285–290
   PubMed Web of Science ®Google Scholar
• Bonnefoy J. Y., Henchoz S., Hardie D., Holder M. J., Gordon J. A subset of anti‐CD21 antibodies promote the rescue of germinal center B cells from apoptosis. Eur. J. Immunol. 1993; 23: 969–972
   PubMed Web of Science ®Google Scholar
• Kolb J. P., Abadie A., Paul‐Eugene N., Capron M., Sarfati M., Dugas B., Delespesse G. Ligation of CD23 triggers cyclic AMP generation in human B lymphocytes. J. Immunol 1992; 150: 4798–4809
   Web of Science ®Google Scholar
• Brizard A., Morel F., Lecron J. C., Dreyfus B., Brizard F., Barra A., Preud'homme J. L. Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23. Leuk. Lymphoma 1994; 14: 311–318
   PubMed Web of Science ®Google Scholar
• Bonnefoy J. Y., Lecoanet‐Henchoz S., Aubry J. P., Gauchat J. F., Graber P. CD23 and B‐cell activation. Curr. Opin. Immunol 1995; 7: 355–359
   PubMed Web of Science ®Google Scholar
• Fournier S., Rubio M., Delespesse G., Sarfati M. Role for low‐affinity receptor for IgE (CD23) in normal and leukemic B‐cell proliferation. Blood 1994; 84: 1881–1886
   PubMed Web of Science ®Google Scholar
• Bjorck P., Elenstrom‐Magnusson C., Rosen A., Severinson E., Paulie S. CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes. Eur. J. Immunol 1993; 23: 1771–1775
   PubMed Web of Science ®Google Scholar
• Aubry J. P., Pochon S., Graber P., Jansen K. U., Bonnefoy J. Y. CD21 is a ligand for CD23 and regulates IgE production. Nature 1992; 358: 505–507
   PubMed Web of Science ®Google Scholar
• Grosjean I., Lachaux A., Bella C., Aubry J. P., Bonnefoy J. Y., Kaiserlian D. CD23/CD21 interaction is required for presentation of soluble protein antigen by lym‐phoblastoid B cell lines to specific CD4+ T cell clones. Eur. J. Immunol 1994; 24: 2982–2986
   PubMed Web of Science ®Google Scholar
• Tsoukas C. D., Lambris J. D. Expression of EBV/C3d receptors on T cells: biological significance. Immunol. Today 1993; 14: 56–59
   PubMedGoogle Scholar
• Calender A., Cordier M., Billaud M., Lenoir G. M. Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein‐Barr virus (EBV). Int. J. Cancer 1990; 46: 658–663
   PubMed Web of Science ®Google Scholar
• Cordier M., Calender A., Billaud M., Zimber U., Rousselet G., Pavlish O., Banchereau J., Tursz T., Bornkamm G., Lenoir G. M. Stable transfection of Epstein‐Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B‐cell activation molecules CD21 and CD23. J. Virol 1990; 64: 1002–1013
   PubMed Web of Science ®Google Scholar
• Hardie D. L., Johnson G. D., Khan M., MacLennan I. C. Quantitative analysis of molecules which distinguish functional compartments within germinal centers. Eur. J. Immunol. 1993; 23: 997–1004
   PubMed Web of Science ®Google Scholar
• Banchereau J., Rousset F. Human B lymphocytes: Phenotype, proliferation and differentiation. Adv. Immunol. 1993; 52: 125–262
   Web of Science ®Google Scholar
• Rayhel E. J., Dehoff M. H., Holers V. M. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins. J. Immunol. 1991; 146: 2021–2026
   PubMed Web of Science ®Google Scholar
• Carlsson M., Matsson P., Rosen A., Sundstrom C., Totterman T. H., Nilsson K. Phorbol ester and B cell‐stimulatory factor synergize to induce B‐chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis. Leukemia 1988; 2: 734–744
   PubMed Web of Science ®Google Scholar
• Fournier S., Yang L. P., Delespesse G., Rubio M., Biron G., Sarfati M. The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia. Br. J. Haematol. 1995; 89: 373–379
   PubMed Web of Science ®Google Scholar
• Maddy A. H., Sanderson A., Mackie M. J., Smith S. K. The role of cell maturation in the generation of pheno‐typic heterogeneity in B‐cell chronic lymphocytic leukaemia. Immunology 1989; 68: 346–352
   PubMed Web of Science ®Google Scholar
• Berrebi A., Bassous‐Guedj L., Vorst E., Dagan S., Shtalrid M., Freedman A. Further characterization of pro‐lymphocytic leukemia cells as a tumor Deactivated B cells. Am. J. Hematol. 1990; 34: 181–185
   PubMed Web of Science ®Google Scholar
• Shubinsky G., Ben‐Bassat H., Schlesinger M. The effect of IL‐4 on the phenotype of a human B‐cell lymphoma line (Farage) lacking immunoglobulin expression. Immunol. Lett. 1993; 36: 37–42
   PubMed Web of Science ®Google Scholar
• Shubinsky G., Schlesinger M. Kinetics of the pleiotropic effect of interleukin 4 on the surface properties of human B‐lymphoma cells. Leuk. Lvmphoma 1994; 15: 333–340
   PubMed Web of Science ®Google Scholar
• Ben‐Bassat H., Polliack A., Schlomai Z., Kohn G., Hadar R., Rabinowitz R., Leizerowitz R., Matutes E., Bucjier V., Brock‐Simoni F., Okon E., Livni N., Schlesinger M. Farage, a novel early B cell lymphoma line with tri‐somy 11. Leuk. Lymphoma 1992; 6: 513–521
   Web of Science ®Google Scholar
• Aubry J. P., Pochon S., Gauchat J. F., Nueda‐Marin A., Holers V. M., Graber P., Siegfried C., Bonnefoy J. Y. CD23 interacts with a new functional extracytoplas‐mic domain involving N‐linked oligosaccharides on CD21. J. Immunol. 1994; 152: 5806–5813
   PubMed Web of Science ®Google Scholar
• Cordier‐Bussat M., Billaud M., Calender A., Lenoir G. M. Epstein‐Barr virus (EBV) nuclear‐antigen‐2‐induced up‐regulation of CD21 and CD23 molecules is dependent on a permissive cellular context. Int. J. Cancer 1993; 53: 153–160
   PubMed Web of Science ®Google Scholar
• Cohen J. I., Wang F., Kieff E. Epstein‐Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J. Virol 1991; 65: 2545–2554
   PubMed Web of Science ®Google Scholar
• Lee C. E., Yoon S. R., Pyun K. H. Interleukin‐4 signals regulating CD23 gene expression in human B cells: protein kinase C‐independent signaling pathways. Cell. Immunol. 1993; 146: 171–185
   PubMed Web of Science ®Google Scholar
• Kosmas C., Epenetos A. A., Courtenay‐Luck N. S. Effects of phorbol esters and cytokines (interleukin‐2, ‐4, and ‐6) on the proliferation and surface phenotype of Epstein‐Barr virus immortalised human B lymphocytes. Leuk. Lymphoma 1992; 8: 109–115
   PubMed Web of Science ®Google Scholar
• Shubinsky G., Schlesinger M. The mechanism of interleukin 4 induced down‐regulation of CD38 on human B cells. Cell. Immunol. 1996, In press
   PubMed Web of Science ®Google Scholar
• Cho Y. J., Hwang O., Moon H. B. Intracellular induction pathways for CD23 antigen and surface immunoglobulins in human tonsillar B cells: the roles of protein kinase C and tyrosine kinase‐mediated signals. Cell. Immunol. 1993; 152: 176–185
   PubMed Web of Science ®Google Scholar
• Finney M., Guy G. R., Michell R. H., Gordon J., Dugas B., Rigley K. P., Callard R. E. Interleukin 4 activates human B lymphocytes via transient inositol lipid hydrolysis and delayed cyclic adenosine monophosphate generation. Eur. J. Immunol 1990; 20: 151–156
   PubMed Web of Science ®Google Scholar